These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 4729905)
1. Clinical biostatistics. 23. The role of randomization in sampling, testing, allocation, and credulous idolatry. 2. Feinstein AR Clin Pharmacol Ther; 1973; 14(5):898-915. PubMed ID: 4729905 [No Abstract] [Full Text] [Related]
2. Clinical biostatistics. XXII. The role of randomization in sampling, testing, allocation, and credulous idolatry. Feinstein AR Clin Pharmacol Ther; 1973; 14(4):601-15. PubMed ID: 4723269 [No Abstract] [Full Text] [Related]
3. Clinical biostatistics. XXIV. The role of randomization in sampling, testing, allocation, and credulous idolatry (conclusion). Feinstein AR Clin Pharmacol Ther; 1973; 14(6):1035-51. PubMed ID: 4584149 [No Abstract] [Full Text] [Related]
4. Methods of randomization in controlled clinical trials. Moeschberger ML; Williams JA; Brown CG Am J Emerg Med; 1985 Sep; 3(5):467-73. PubMed ID: 4041198 [TBL] [Abstract][Full Text] [Related]
5. Randomization by cluster. Sample size requirements and analysis. Donner A; Birkett N; Buck C Am J Epidemiol; 1981 Dec; 114(6):906-14. PubMed ID: 7315838 [No Abstract] [Full Text] [Related]
6. Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests. Feinstein AR Clin Pharmacol Ther; 1975 Jan; 17(1):104-16. PubMed ID: 1122664 [No Abstract] [Full Text] [Related]
7. Calculation of power for matched pair studies when randomization is by group. Shipley MJ; Smith PG; Dramaix M Int J Epidemiol; 1989 Jun; 18(2):457-61. PubMed ID: 2767863 [TBL] [Abstract][Full Text] [Related]
8. Planning the size of a cohort study in the presence of both losses to follow-up and non-compliance. Palta M; McHugh R J Chronic Dis; 1980; 33(8):501-12. PubMed ID: 7380984 [No Abstract] [Full Text] [Related]
9. Curtailed binomial sampling procedures for clinical trials with paired data. Herrmann N; Szatrowski TH Control Clin Trials; 1985 Mar; 6(1):25-37. PubMed ID: 3987301 [TBL] [Abstract][Full Text] [Related]
11. Clinical biostatistics. XXX. Biostatistical problems in 'compliance bias'. Feinstein AR Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):846-57. PubMed ID: 4426153 [No Abstract] [Full Text] [Related]
12. Sampling: how to fix the odds--Part 1. How Eval Health Programs; 1980 Jul; 3(7):1-6. PubMed ID: 10247262 [No Abstract] [Full Text] [Related]
13. Clinical biostatistics. XXXVII. Demeaned errors, confidence games, nonplussed minuses, inefficient coefficients, and other statistical disruptions of scientific communication. Feinstein AR Clin Pharmacol Ther; 1976 Nov; 20(5):617-31. PubMed ID: 985637 [No Abstract] [Full Text] [Related]
14. Mathematical aspects of medical research in Ceylon. Jayewardene CH Ceylon Med J; 1968 Dec; 13(4):201-6. PubMed ID: 5728920 [No Abstract] [Full Text] [Related]
15. Statistical concepts fundamental to investigations. Moses LE N Engl J Med; 1985 Apr; 312(14):890-7. PubMed ID: 3883178 [No Abstract] [Full Text] [Related]
16. Sample heterogeneity versus sample homogeneity in cancer nursing research. Dixon JK; Moritz D Oncol Nurs Forum; 1983; 10(1):40-5. PubMed ID: 6553312 [No Abstract] [Full Text] [Related]
17. Alternative tests for heterogeneity of variance; some Monte Carlo results. Pearson ES Biometrika; 1966 Jun; 53(1):229-34. PubMed ID: 5964061 [No Abstract] [Full Text] [Related]